GL1X · GenesisL1 explorer

Research workbench

Crystal structure of selective IRE1a inhibitor 29 at the enzyme active site

Analyse Crystal structure of selective IRE1a inhibitor 29 at the enzyme active site in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
8UVL
Type
protein
Length
403 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.43
Source
Homo sapiens
Molecule
Serine/threonine-protein kinase/endoribonuclease IRE1
EC
2.7.11.1, 3.1.26.-
UniProt
O75460
Ligands
XOE
Pockets
4 · best druggability 0.73

Structure

x-ray diffraction · resolution 2.43 · 1 distinct chain · 46% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASerine/threonine-protein kinase/endoribonuclease IRE1 (EC 2.7.11.1, 3.1.26.-)protein40346% helix, 14% strandO75460

Ligands and binding sites

  • XOE · 1-phenyl-N-(2,3,6-trifluoro-4-{[(3M)-3-(2-{[(3R,5R)-5-fluoropiperidin-3-yl]amino}pyrimidin-4-yl)pyridin-2-yl]oxy}phenyl)methanesulfonamide · ligand · chains A
  • EDO · 1,2-ethanediol · additive · 8 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14380.730.8342XOE
21080.510.8220empty
31920.500.7627EDO
4510.270.7412EDO

Compared structures

  • O75460 · AlphaFold monomer V2.0 prediction for SERINE/THREONINE-protein KINASE/ENDORIBONUCLEASE… · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.